9. REFERENCES

1.Boorjian, S.A., et al. Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol, 2011. 60: 1266.
https://www.ncbi.nlm.nih.gov/pubmed/21871713

2.van der Heijden, A.G., et al. EAU Guidelines on Muscle-invasive and metastatic bladder cancer. Edn. presented at the 41st EAU Annual Congress London, 2026.
https://uroweb.org/guidelines/muscle-invasive-and-metastatic-bladder-cancer

3.Gakis, G., et al. European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update. Eur Urol Oncol, 2020. 3: 424.
https://www.ncbi.nlm.nih.gov/pubmed/32605889

4.Phillips, B., et al. Oxford Centre for Evidence-based Medicine Levels of Evidence. Updated by Jeremy Howick March 2009.
https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

5.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.
https://www.ncbi.nlm.nih.gov/pubmed/18467413

6.Gatta, G., et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer, 2011. 47: 2493.
https://www.ncbi.nlm.nih.gov/pubmed/22033323

7.Brierley, J.D., et al., TNM classification of malignant tumors. UICC International Union Against Cancer. 2025, Wiley/Blackwell. p. 208.
https://books.google.nl/books?id=WeJhEQAAQBAJ&amp

8.RARECARENet. Surveillance of Rare Cancers in Europe. 2019. 2025.
http://www.rarecare.eu/default.asp

9.Wenzel, M., et al. Incidence rates and contemporary trends in primary urethral cancer. Cancer Causes Control, 2021. 32: 627.
https://www.ncbi.nlm.nih.gov/pubmed/33751293

10.Wenzel, M., et al. Sex-Related Differences Include Stage, Histology, and Survival in Urethral Cancer Patients. Clin Genitourin Cancer, 2021. 19: 135.
https://www.ncbi.nlm.nih.gov/pubmed/33526327

11.Krukowski, J., et al. Primary urethral carcinoma - unexpected cause of urethral stricture. Case report and review of the literature. Med Ultrason, 2019. 21: 494.
https://www.ncbi.nlm.nih.gov/pubmed/31765461

12.Guo, H., et al. Lichen Sclerosus Accompanied by Urethral Squamous Cell Carcinoma: A Retrospective Study From a Urethral Referral Center. Am J Mens Health, 2018. 12: 1692.
https://www.ncbi.nlm.nih.gov/pubmed/29926751

13.Colapinto, V., et al. Primary carcinoma of the male urethra developing after urethroplasty for stricture. J Urol, 1977. 118: 581.
https://www.ncbi.nlm.nih.gov/pubmed/916053

14.Mohanty, N.K., et al. Squamous cell carcinoma of perineal urethrostomy. Urol Int, 1995. 55: 118.
https://www.ncbi.nlm.nih.gov/pubmed/8533195

15.Sawczuk, I., et al. Post urethroplasty squamous cell carcinoma. N Y State J Med, 1986. 86: 261.
https://www.ncbi.nlm.nih.gov/pubmed/3459083

16.Mohan, H., et al. Squamous cell carcinoma of the prostate. Int J Urol, 2003. 10: 114.
https://www.ncbi.nlm.nih.gov/pubmed/12588611

17.Arva, N.C., et al. Diagnostic dilemmas of squamous differentiation in prostate carcinoma case report and review of the literature. Diagn Pathol, 2011. 6: 46.
https://www.ncbi.nlm.nih.gov/pubmed/21627811

18.Cupp, M.R., et al. Detection of human papillomavirus DNA in primary squamous cell carcinoma of the male urethra. Urology, 1996. 48: 551.
https://www.ncbi.nlm.nih.gov/pubmed/8886059

19.Wiener, J.S., et al. Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. Cancer Res, 1992. 52: 5018.
https://www.ncbi.nlm.nih.gov/pubmed/1325290

20.Ahmed, K., et al. Urethral diverticular carcinoma: an overview of current trends in diagnosis and management. Int Urol Nephrol, 2010. 42: 331.
https://www.ncbi.nlm.nih.gov/pubmed/19649767

21.Chung, D.E., et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol, 2010. 183: 2265.
https://www.ncbi.nlm.nih.gov/pubmed/20400161

22.Thomas, A.A., et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol, 2008. 180: 2463.
https://www.ncbi.nlm.nih.gov/pubmed/18930487

23.Libby, B., et al. Non-surgical treatment of primary female urethral cancer. Rare Tumors, 2010. 2: e55.
https://www.ncbi.nlm.nih.gov/pubmed/21139970

24.Altman, D., et al. Cancer Risk After Midurethral Sling Surgery Using Polypropylene Mesh. Obstet Gynecol, 2018. 131: 469.
https://www.ncbi.nlm.nih.gov/pubmed/29420401

25.Gandhi, J.S., et al. Clear cell adenocarcinoma of the male urethral tract. Indian J Pathol Microbiol, 2012. 55: 245.
https://www.ncbi.nlm.nih.gov/pubmed/22771656

26.Mehra, R., et al. Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol, 2014. 184: 584.
https://www.ncbi.nlm.nih.gov/pubmed/24389164

27.Visser, O., et al. Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer, 2012. 48: 456.
https://www.ncbi.nlm.nih.gov/pubmed/22119351

28.Rabbani, F. Prognostic factors in male urethral cancer. Cancer, 2011. 117: 2426.
https://www.ncbi.nlm.nih.gov/pubmed/24048790

29.Aleksic, I., et al. Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival. Urol Ann, 2018. 10: 170.
https://www.ncbi.nlm.nih.gov/pubmed/29719329

30.Sui, W., et al. Outcomes and Prognostic Factors of Primary Urethral Cancer. Urology, 2017. 100: 180.
https://www.ncbi.nlm.nih.gov/pubmed/27720774

31.Wenzel, M., et al. Epidemiology of Unconventional Histological Subtypes of Urethral Cancer. Urol Int, 2023. 107: 15.
https://www.ncbi.nlm.nih.gov/pubmed/35882213

32.Greiman, A.K., et al. Urethral diverticulum: A systematic review. Arab J Urol, 2019. 17: 49.
https://www.ncbi.nlm.nih.gov/pubmed/31258943

33.WHO Classification of Tumours Editorial Board, WHO Classification of Tumours, Urinary and Male Genital Tumours. 5th Edition ed. Vol. 8. 2022.
https://publications.iarc.who.int/Book-And-Report-Series/Who-Classification-Of-Tumours/Urinary-And-Male-Genital-Tumours-2022

34.Shanks, J.H., et al. Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology, 2019. 75: 453.
https://www.ncbi.nlm.nih.gov/pubmed/31009090

35.Gheiler, E.L., et al. Management of primary urethral cancer. Urology, 1998. 52: 487.
https://www.ncbi.nlm.nih.gov/pubmed/9730466

36.Karnes, R.J., et al. Surgery for urethral cancer. Urol Clin North Am, 2010. 37: 445.
https://www.ncbi.nlm.nih.gov/pubmed/20674699

37.Blaivas, J.G., et al. Periurethral masses: etiology and diagnosis in a large series of women. Obstet Gynecol, 2004. 103: 842.
https://www.ncbi.nlm.nih.gov/pubmed/15121554

38.Wojcik, E.M., et al., The Paris System for Reporting Urinary Cytology. 2022, Switzerland.
https://link.springer.com/book/10.1007/978-3-030-88686-8

39.Touijer, A.K., et al. Role of voided urine cytology in diagnosing primary urethral carcinoma. Urology, 2004. 63: 33.
https://www.ncbi.nlm.nih.gov/pubmed/14751342

40.Gakis, G., et al. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int, 2016. 97: 134.
https://www.ncbi.nlm.nih.gov/pubmed/27462702

41.Samm, B.J., et al. Penectomy: a technique to reduce blood loss. Urology, 1999. 53: 393.
https://www.ncbi.nlm.nih.gov/pubmed/9933061

42.Donat, S.M., et al. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J Urol, 2001. 165: 1580.
https://www.ncbi.nlm.nih.gov/pubmed/11342921

43.Schubert, T., et al. The Predictive Accuracy between Clinical Staging and Pathological Staging in Patients with Primary Urethral Carcinoma. Journal of Urology, 2019. 201: e135.
https://www.auajournals.org/doi/abs/10.1097/01.JU.0000555184.87550.3c

44.Del Gaizo, A., et al. Magnetic resonance imaging of solid urethral and peri-urethral lesions. Insights Imaging, 2013. 4: 461.
https://www.ncbi.nlm.nih.gov/pubmed/23686749

45.Itani, M., et al. MRI of female urethra and periurethral pathologies. Int Urogynecol J, 2016. 27: 195.
https://www.ncbi.nlm.nih.gov/pubmed/26209954

46.Stewart, S.B., et al. Imaging tumors of the penis and urethra. Urol Clin North Am, 2010. 37: 353.
https://www.ncbi.nlm.nih.gov/pubmed/20674692

47.Kim, B., et al. Imaging of the male urethra. Semin Ultrasound CT MR, 2007. 28: 258.
https://www.ncbi.nlm.nih.gov/pubmed/17874650

48.Raman, S.P., et al. Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography. Radiol Clin North Am, 2017. 55: 225.
https://www.ncbi.nlm.nih.gov/pubmed/28126213

49.Gourtsoyianni, S., et al. MRI at the completion of chemoradiotherapy can accurately evaluate the extent of disease in women with advanced urethral carcinoma undergoing anterior pelvic exenteration. Clin Radiol, 2011. 66: 1072.
https://www.ncbi.nlm.nih.gov/pubmed/21839430

50.Laudicella, R., et al. (18)F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma. Nucl Med Mol Imaging, 2019. 53: 296.
https://www.ncbi.nlm.nih.gov/pubmed/31456863

51.Dayyani, F., et al. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol, 2013. 31: 1171.
https://www.ncbi.nlm.nih.gov/pubmed/22534087

52.Gakis, G., et al. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol, 2016. 34: 97.
https://www.ncbi.nlm.nih.gov/pubmed/25981402

53.Werntz, R.P., et al. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma. Urol Oncol, 2018. 36: 526 e1.
https://www.ncbi.nlm.nih.gov/pubmed/30446445

54.Naumann, C.M., et al. Reliability of dynamic sentinel node biopsy combined with ultrasound-guided removal of sonographically suspicious lymph nodes as a diagnostic approach in patients with penile cancer with palpable inguinal lymph nodes. Urol Oncol, 2015. 33: 389 e9.
https://www.ncbi.nlm.nih.gov/pubmed/25934562

55.Carroll, P.R., et al. Surgical anatomy of the male and female urethra. Urol Clin North Am, 1992. 19: 339.
https://www.ncbi.nlm.nih.gov/pubmed/1574824

56.Sharp, D., et al., Surgery of penile and urethral carcinoma, in Campbell-Walsh Urology, D. McDougal, et al., Editors. 2016, Saunders Elsevier: Philadelphia, PA, USA.
https://books.google.nl/books/about/Campbell_Walsh_Urology_11th_Edition_Revi.html?id=RR2KCwAAQBAJ&amp

57.Morra, S., et al. Contemporary conditional cancer-specific survival rates in surgically treated nonmetastatic primary urethral carcinoma. J Surg Oncol, 2024. 129: 1348.
https://www.ncbi.nlm.nih.gov/pubmed/38606531

58.Abudurexiti, M., et al. Prognosis of rare pathological primary urethral carcinoma. Cancer Manag Res, 2018. 10: 6815.
https://www.ncbi.nlm.nih.gov/pubmed/30584373

59.Swartz, M.A., et al. Incidence of primary urethral carcinoma in the United States. Urology, 2006. 68: 1164.
https://www.ncbi.nlm.nih.gov/pubmed/17141838

60.Wu, J., et al. Primary tumor surgery improves survival in non-metastatic primary urethral carcinoma patients: a large population-based investigation. BMC Cancer, 2021. 21: 857.
https://www.ncbi.nlm.nih.gov/pubmed/34315433

61.Wenzel, M., et al. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer. Urol Oncol, 2021. 39: 369 e9.
https://www.ncbi.nlm.nih.gov/pubmed/33309509

62.Champ, C.E., et al. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology, 2012. 80: 374.
https://www.ncbi.nlm.nih.gov/pubmed/22857759

63.Morra, S., et al. Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients. Urol Oncol, 2024. 42: 161 e17.
https://www.ncbi.nlm.nih.gov/pubmed/38320935

64.Panettieri, V., et al. External Validation of a Predictive Model of Urethral Strictures for Prostate Patients Treated With HDR Brachytherapy Boost. Front Oncol, 2020. 10: 910.
https://www.ncbi.nlm.nih.gov/pubmed/32596153

65.Wenzel, M., et al. Epidemiology of Unconventional Histological Subtypes of Urethral Cancer. Urol Int, 2023. 107(1): 15.
https://pubmed.ncbi.nlm.nih.gov/35882213/

66.Derksen, J.W., et al. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol, 2013. 31: 147.
https://www.ncbi.nlm.nih.gov/pubmed/22614443

67.Wenzel, M., et al. Comparison Between Urothelial and Non-Urothelial Urethral Cancer. Front Oncol, 2020. 10: 629692.
https://www.ncbi.nlm.nih.gov/pubmed/33585257

68.Stone, B.V., et al. The effect of centralization of care on overall survival in primary urethral cancer. Urol Oncol, 2021. 39: 133 e17.
https://www.ncbi.nlm.nih.gov/pubmed/33268273

69.Gakis, G., et al. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol, 2018. 36: 10 e7.
https://www.ncbi.nlm.nih.gov/pubmed/29055518

70.Dalbagni, G., et al. Male urethral carcinoma: analysis of treatment outcome. Urology, 1999. 53: 1126.
https://www.ncbi.nlm.nih.gov/pubmed/10367840

71.Smith, Y., et al. Penile-preserving surgery for male distal urethral carcinoma. BJU Int, 2007. 100: 82.
https://www.ncbi.nlm.nih.gov/pubmed/17488307

72.Pedrosa, J.A., et al. Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series. Int Urol Nephrol, 2014. 46: 1551.
https://www.ncbi.nlm.nih.gov/pubmed/24633698

73.Kulkarni, M., et al. MP10-16 Substitution urethroplasty for treatment of distal urethral carcinoma and carcinoma in situ. J. Urol 193: e117.
http://dx.doi.org/10.1016/j.juro.2015.02.417

74.Torbrand, C., et al. Diagnosing Distal Urethral Carcinomas in Men Might Be Only the Tip of the Iceberg. Clin Genitourin Cancer, 2017. 15: e1131.
https://www.ncbi.nlm.nih.gov/pubmed/28784424

75.Dimarco, D.S., et al. Surgical treatment for local control of female urethral carcinoma. Urol Oncol, 2004. 22: 404.
https://www.ncbi.nlm.nih.gov/pubmed/15464921

76.DiMarco, D.S., et al. Outcome of surgical treatment for primary malignant melanoma of the female urethra. J Urol, 2004. 171: 765.
https://www.ncbi.nlm.nih.gov/pubmed/14713806

77.Garden, A.S., et al. Primary carcinoma of the female urethra. Results of radiation therapy. Cancer, 1993. 71: 3102.
https://www.ncbi.nlm.nih.gov/pubmed/8490839

78.Milosevic, M.F., et al. Urethral carcinoma in women: results of treatment with primary radiotherapy. Radiother Oncol, 2000. 56: 29.
https://www.ncbi.nlm.nih.gov/pubmed/10869752

79.Zinman, L.N., et al. Management of Proximal Primary Urethral Cancer: Should Multidisciplinary Therapy Be the Gold Standard? Urol Clin North Am, 2016. 43: 505.
https://www.ncbi.nlm.nih.gov/pubmed/27717436

80.Cahn, D.B., et al. Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis. Urol Oncol, 2017. 35: 670 e15.
https://www.ncbi.nlm.nih.gov/pubmed/28803701

81.Dayyani, F., et al. Management of advanced primary urethral carcinomas. BJU Int, 2014. 114: 25.
https://www.ncbi.nlm.nih.gov/pubmed/24447439

82.Peyton, C.C., et al. Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience. Clin Genitourin Cancer, 2018. 16: e1003.
https://www.ncbi.nlm.nih.gov/pubmed/29859736

83.Mano, R., et al. Primary urethral cancer: treatment patterns and associated outcomes. BJU Int, 2020. 126: 359.
https://www.ncbi.nlm.nih.gov/pubmed/32336001

84.Celtik, K., et al. Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database. Clin Genitourin Cancer, 2022. 20: 244.
https://www.ncbi.nlm.nih.gov/pubmed/35181268

85.Gakis, G., et al. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol, 2015. 26: 1754.
https://www.ncbi.nlm.nih.gov/pubmed/25969370

86.Kent, M., et al. Combined chemoradiation as primary treatment for invasive male urethral cancer. J Urol, 2015. 193: 532.
https://www.ncbi.nlm.nih.gov/pubmed/25088950

87.Gakis, G. Editorial Comment to Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 424.
https://www.ncbi.nlm.nih.gov/pubmed/24251884

88.Itoh, J., et al. Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol, 2014. 21: 422.
https://www.ncbi.nlm.nih.gov/pubmed/24251859

89.Hara, I., et al. Successful treatment for squamous cell carcinoma of the female urethra with combined radio- and chemotherapy. Int J Urol, 2004. 11: 678.
https://www.ncbi.nlm.nih.gov/pubmed/15285764

90.Cohen, M.S., et al. Coordinated chemoradiation therapy with genital preservation for the treatment of primary invasive carcinoma of the male urethra. J Urol, 2008. 179: 536.
https://www.ncbi.nlm.nih.gov/pubmed/18076921

91.Son, C.H., et al. Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Int J Radiat Oncol Biol Phys, 2018. 102: 304.
https://www.ncbi.nlm.nih.gov/pubmed/29908944

92.Patschan, O., et al. Systematic Review of the Role of BCG in the Treatment of Urothelial Carcinoma of the Prostatic Urethra. Bladder Cancer, 2021. 7: 213.
https://www.ncbi.nlm.nih.gov/pubmed/38994530

93.Njinou Ngninkeu, B., et al. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases. J Urol, 2003. 169: 149.
https://www.ncbi.nlm.nih.gov/pubmed/12478124

94.Hillyard, R.W., Jr., et al. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin. J Urol, 1988. 139: 290.
https://www.ncbi.nlm.nih.gov/pubmed/3339727

95.Solsona, E., et al. The prostate involvement as prognostic factor in patients with superficial bladder tumors. J Urol, 1995. 154: 1710.
https://www.ncbi.nlm.nih.gov/pubmed/7563328

96.Vazina, A., et al. Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol, 2004. 171: 1830.
https://www.ncbi.nlm.nih.gov/pubmed/15076287

97.Galsky, M.D., et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer. J Immunother Cancer, 2021. 9.
https://www.ncbi.nlm.nih.gov/pubmed/34266883

98.Shukla, C.J., et al. Palliation of male genital cancers. Clin Oncol (R Coll Radiol), 2010. 22: 747.
https://www.ncbi.nlm.nih.gov/pubmed/20800458